Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name TINCR
   Synonyms TINCR, LINC00036, NCRNA00036, PLAC2, onco-lncRNA-16
   Region GRCh38_19:5558167-5578349    Sequence
   Ensembl ENSG00000223573
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name colorectal cancer
   ICD-0-3 C19.9  
   Methods qPCR, Western blot, RIP, Luciferase reporter assay, Luciferase reporter assay, Flow cytometry assay, Cell proliferation assay etc.
   Sample CRC tissues, cell lines (FHC, LOVO, M5, HCT116, HT29, RKO, LS174T, SW480, SW620, and HEK294)
   Expression Pattern down-regulated
   Function Description

TINCR was statistically downregulated in CRC tissues and metastatic CRC cell lines compared with their counterparts. TINCR was reversely correlated with CRC progression and promoted tumor cells growth, metastasis in vivo and in vitro. In addition, we also found that TINCR specifically bound to EpCAM through RNA IP and RNA pull down assays. Loss of TINCR promoted hydrolysis of EpCAM and then released EpICD, subsequently, activated the Wnt/B-catenin pathway. Further studies shown that c-Myc repressed the expression of TINCR through repressing sp1 transcriptive activity, which established a positive feedback loop controlling c-Myc and TINCR expression.

   Pubmed ID 27009809
   Year 2016
   Title Loss of TINCR expression promotes proliferation, metastasis through activating EpCAM cleavage in colorectal cancer.
   External Links
   Links for  TINCR GenBank       HGNC       lncrnadb       Noncode
   Links for  colorectal cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.